These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1361480)

  • 21. Critical determination of the frequency of c-erbB-2 amplification in breast cancer.
    Hubbard AL; Doris CP; Thompson AM; Chetty U; Anderson TJ
    Br J Cancer; 1994 Sep; 70(3):434-9. PubMed ID: 7915911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.
    Kallioniemi OP; Holli K; Visakorpi T; Koivula T; Helin HH; Isola JJ
    Int J Cancer; 1991 Nov; 49(5):650-5. PubMed ID: 1682277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
    Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
    Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM
    J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma.
    Pavelic ZP; Pavelic L; Lower EE; Gapany M; Gapany S; Barker EA; Preisler HD
    Cancer Res; 1992 May; 52(9):2597-602. PubMed ID: 1348967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of chemotactic factor receptor 5 gene with breast cancer.
    Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
    Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.
    Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi OP
    J Clin Oncol; 1993 Jan; 11(1):36-43. PubMed ID: 8093367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression.
    Wiener JR; Kerns BJ; Harvey EL; Conaway MR; Iglehart JD; Berchuck A; Bast RC
    J Natl Cancer Inst; 1994 Mar; 86(5):372-8. PubMed ID: 7905928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.
    Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE
    Anticancer Res; 1997; 17(2B):1319-30. PubMed ID: 9137492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
    Isola J; Visakorpi T; Holli K; Kallioniemi OP
    J Natl Cancer Inst; 1992 Jul; 84(14):1109-14. PubMed ID: 1352359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of elevated expression of the c-erbB-2 protein with spread of breast cancer.
    Yamada Y; Yoshimoto M; Murayama Y; Ebuchi M; Mori S; Yamamoto T; Sugano H; Toyoshima K
    Jpn J Cancer Res; 1989 Dec; 80(12):1192-8. PubMed ID: 2576425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the c-erbB-2 gene product as detected in cytologic aspirates in breast cancer.
    Allan SM; Fernando IN; Sandle J; Trott PA
    Acta Cytol; 1993; 37(6):981-2. PubMed ID: 7902634
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of a multiple S1 nuclease protection assay to monitor changes in RNA levels for type 1 phosphatase and several proto-oncogenes in response to insulin.
    Thompson DB; Sommercorn J
    J Biol Chem; 1992 Mar; 267(9):5921-6. PubMed ID: 1372896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer.
    Tokunaga Y; Urano T; Furukawa K; Kondo H; Kanematsu T; Shiku H
    Int J Cancer; 1993 Aug; 55(1):66-71. PubMed ID: 8102131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neu (c-erbB-2), a tumor marker in carcinoma of the female breast.
    Maguire HC; Greene MI
    Pathobiology; 1990; 58(6):297-303. PubMed ID: 1981830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies for the analysis of oncogene overexpression. Studies of the neu oncogene in breast carcinoma.
    Naber SP; Tsutsumi Y; Yin S; Zolnay SA; Mobtaker H; Marks PJ; McKenzie SJ; DeLellis RA; Wolfe HJ
    Am J Clin Pathol; 1990 Aug; 94(2):125-36. PubMed ID: 1973590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent abnormal expression of ERBB-2, EGFR, and p53 genes and clinical disease progression of breast carcinoma.
    Visscher DW; Castellani R; Wykes SM; Sarkar FH; Hussain ME
    Breast Cancer Res Treat; 1993 Dec; 28(3):261-6. PubMed ID: 7912562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
    Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
    Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance.
    Guérin M; Gabillot M; Mathieu MC; Travagli JP; Spielmann M; Andrieu N; Riou G
    Int J Cancer; 1989 Feb; 43(2):201-8. PubMed ID: 2563719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters.
    Odagiri E; Kanada N; Jibiki K; Demura R; Aikawa E; Demura H
    Cancer; 1994 Jun; 73(12):2978-84. PubMed ID: 7911069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.